OPKO Health beats Q2 2026 estimates with $163.5M revenue and $8.4M net loss ($0.01/share), issues Q3 and FY26 revenue guidance
https://finviz.com/stock?t=OPK&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.